660 — Wai Chun Bio Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$15.35m
- HK$184.81m
- HK$370.07m
- 27
- 78
- 29
- 40
Annual cashflow statement for Wai Chun Bio Technology, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 18 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9.06 | 1.61 | 3.78 | -5.7 | -78.2 |
| Depreciation | |||||
| Non-Cash Items | 8.02 | 13 | 26.2 | 20.6 | 81.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.15 | -21.4 | -41.4 | 20 | 37.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 14.3 | -0.413 | 4.78 | 48.9 | 52.1 |
| Capital Expenditures | -13 | -12.5 | -16.8 | -28.2 | -40 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.184 | 0.026 | 0.136 | 0.038 | 0.012 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.8 | -12.5 | -16.7 | -28.1 | -40 |
| Financing Cash Flow Items | -2.81 | -5.15 | -4.42 | -3.56 | -2.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.868 | 11.5 | 12.7 | -21.5 | -16.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.872 | 0.037 | 2.07 | -1.21 | -4.15 |